YU38898A - Novel composition containing cyclosporin and improved process for obtaining soft gelatin capsules containing cyclosporin - Google Patents

Novel composition containing cyclosporin and improved process for obtaining soft gelatin capsules containing cyclosporin

Info

Publication number
YU38898A
YU38898A YU38898A YU38898A YU38898A YU 38898 A YU38898 A YU 38898A YU 38898 A YU38898 A YU 38898A YU 38898 A YU38898 A YU 38898A YU 38898 A YU38898 A YU 38898A
Authority
YU
Yugoslavia
Prior art keywords
containing cyclosporin
composition containing
gelatin capsules
improved process
soft gelatin
Prior art date
Application number
YU38898A
Other languages
Serbo-Croatian (sh)
Serbian (sr)
Other versions
YU49404B (en
Inventor
Amarijt Singh
Rajesh Jain
Original Assignee
Panacea Biotec Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Limited filed Critical Panacea Biotec Limited
Publication of YU38898A publication Critical patent/YU38898A/en
Publication of YU49404B publication Critical patent/YU49404B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A61P33/12—Schistosomicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Abstract

Opisana je nova, homogena, bez alkohola, slobodno tekuća, bistra i transparentna farmaceutska smesa koja sadrži ciklosporin. Količina ciklosporina je lako merljiva u širokom temperaturnom opsegu od 15В° do 45В°C. Smesa sadrži ciklosporin u hidrofilnom nosaču koji sadrži propilen glikol, transesterifikacioni proizvod triglicerida prirodnog biljnog ulja i polialkilen poliola - kao što je polietilen glikol 6 estar ulja iz koščice kajsije - kao što je Labrafil M1944 i polietilen hidrogenovana ricinusova ulja - kao što je Cremophor RH 40 i glicerol triacetat ili triacetin.A new, homogeneous, alcohol-free, free-flowing, clear and transparent pharmaceutical composition containing cyclosporine is described. The amount of cyclosporine is easily measurable in a wide temperature range from 15V ° to 45V ° C. The mixture contains cyclosporin in a hydrophilic carrier containing propylene glycol, a transesterification product of natural vegetable oil triglycerides and a polyalkylene polyol - such as polyethylene glycol 6 apricot kernel oil ester - such as Labrafil M1944 and polyethylene hydrogenated Crecinor oil - as RH and glycerol triacetate or triacetin.

YU38898A 1997-09-08 1998-09-04 A novel composition containing cyclosporin and improved process for making soft gelatin capsules containing cyslosporin YU49404B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2532DE1997 IN188719B (en) 1997-09-08 1997-09-08

Publications (2)

Publication Number Publication Date
YU38898A true YU38898A (en) 1999-11-22
YU49404B YU49404B (en) 2005-11-28

Family

ID=11092786

Family Applications (1)

Application Number Title Priority Date Filing Date
YU38898A YU49404B (en) 1997-09-08 1998-09-04 A novel composition containing cyclosporin and improved process for making soft gelatin capsules containing cyslosporin

Country Status (10)

Country Link
US (1) US5945398A (en)
JP (1) JP2942556B2 (en)
KR (1) KR100308779B1 (en)
AU (1) AU716855B2 (en)
CA (1) CA2242476A1 (en)
IN (1) IN188719B (en)
MY (1) MY121006A (en)
NZ (1) NZ331534A (en)
UA (1) UA57725C2 (en)
YU (1) YU49404B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US6187747B1 (en) * 1997-09-08 2001-02-13 Panacea Biotech Limited Pharmaceutical composition comprising cyclosporin
US6346511B1 (en) * 1997-09-08 2002-02-12 Panacea Biotec Limited Pharmaceutical composition comprising cyclosporin
US6541517B1 (en) * 1999-09-03 2003-04-01 Donald M. Murphy Treatment of skin disorders
US6117904A (en) * 1999-09-03 2000-09-12 Murphy; Donald M. Treatment of pruritus
AR036852A1 (en) * 2001-10-19 2004-10-06 Isotechnika Inc PRE-CONCENTRATED OF A MICROEMULSION OF CYCLOSPORINE ANALOGS, ITS PREPARATION METHOD AND METHODS TO PRODUCE IMMUNOSUPPRESSION
EP1455753A1 (en) * 2001-12-20 2004-09-15 Bernard Charles Sherman Pharmaceutical compositions comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant
ES2294410T3 (en) * 2004-08-12 2008-04-01 Bauer Maschinen Gmbh METHOD AND DEVICE FOR WORKING THE SOIL.
JP2012188602A (en) * 2011-03-12 2012-10-04 Yokohama Yushi Kogyo Kk Oil-and-fat composition, and process for producing the same
JP6335270B2 (en) * 2013-03-15 2018-05-30 ワーナー チルコット カンパニー， エルエルシーＷａｒｎｅｒ Ｃｈｉｌｃｏｔｔ Ｃｏｍｐａｎｙ， Ｌｌｃ Pharmaceutical soft gelatin capsule dosage form using modified guar gum

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (en) * 1956-03-10 1961-10-27 Surfactants obtained from triglycerides and polyethylene glycol
US4210581A (en) * 1975-11-04 1980-07-01 Sandoz Ltd. Organic compounds
CH614931A5 (en) * 1975-11-04 1979-12-28 Sandoz Ag
DE2819094A1 (en) * 1977-05-10 1978-11-23 Sandoz Ag CYCLOSPORIN DERIVATIVES, THEIR USE AND MANUFACTURING
DE2907460A1 (en) * 1978-03-07 1979-09-13 Sandoz Ag NEW RESORBABLE GALENIC COMPOSITIONS
FR2502951B1 (en) * 1981-04-06 1985-12-06 Sandoz Sa TOPICAL PHARMACEUTICAL COMPOSITIONS IN THE FORM OF A MICRO-EMULSION
AU558155B2 (en) * 1982-02-01 1987-01-22 Sandoz Ltd. Treating multiple sclerosis with dihydro-cyclosporin d
DE3406497A1 (en) * 1984-02-23 1985-09-05 Mueller Bernhard Willi Werner HIGHLY DISPERSAL PHARMACEUTICAL MULTI-COMPONENT SYSTEMS AND METHOD FOR THEIR PRODUCTION
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US4835002A (en) * 1987-07-10 1989-05-30 Wolf Peter A Microemulsions of oil in water and alcohol
US4914188A (en) * 1987-11-16 1990-04-03 Merck & Co., Inc. Novel 6-position cyclosporin analogs as non-immunosuppressive antagonists of cyclosporin binding to cyclophilin
ES2033086T3 (en) * 1988-01-29 1993-03-01 Sankyo Company Limited A PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION.
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
CN1077800C (en) * 1993-07-01 2002-01-16 韩美药品工业株式会社 Cyclosporin soft capsule composition
MY129435A (en) * 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates

Also Published As

Publication number Publication date
US5945398A (en) 1999-08-31
JP2942556B2 (en) 1999-08-30
UA57725C2 (en) 2003-07-15
AU7406898A (en) 1999-03-18
MY121006A (en) 2005-12-30
JPH11147835A (en) 1999-06-02
YU49404B (en) 2005-11-28
CA2242476A1 (en) 1999-03-08
KR100308779B1 (en) 2001-11-15
NZ331534A (en) 1999-10-28
AU716855B2 (en) 2000-03-09
IN188719B (en) 2002-11-02
KR19990029589A (en) 1999-04-26

Similar Documents

Publication Publication Date Title
Gibbs The fine structure of Euglena gracilis with special reference to the chloroplasts and pyrenoids
YU38898A (en) Novel composition containing cyclosporin and improved process for obtaining soft gelatin capsules containing cyclosporin
CA2063791A1 (en) Hard gelatine capsule containing fat-soluble nutrients.
UA35559C2 (en) Pharmaceutical composition, product of corn oil transetherification by glycerol, method of manufacture thereof
AR002960A1 (en) IMPROVED EMULSION FOR TOPIC APPLICATION AND CONTAINING GELATIN CAPSULE.
ATE65023T1 (en) PHARMACEUTICAL AGENT.
AR004483A1 (en) COMPOUNDS FOR THERAPY USE INCLUDING A 1,3-PROPANE DIOL WASTE AS A BINDING AGENT BETWEEN FATTY ACID WASTE AND A BIOACTIVE WASTE, USES OF THESE COMPOUNDS AND MEDICINES, FOODS AND TREATMENT AND TREATMENT TO SUCH COMPOUNDS
TR199501361A2 (en) New formulas of cyclosporine for oral administration with simple composition and high bioavailability and the process for their production.
IL101225A0 (en) Bi-and tricyclic amino alcohol esters,their preparation and pharmaceutical compositions containing them
DE69619700T2 (en) BIOLOGICALLY ACTIVE PREPARATION CONTAINING CYCLOSPORIN
Cantino et al. Life history of the motile spore of Blastocladiella emersonii: a study in cell differentiation
KR850002396A (en) Hair Treatment Composition
ATE14981T1 (en) PHARMACEUTICAL PREPARATION AND ITS MANUFACTURE.
IT1240768B (en) PHARMACEUTICAL COMPOSITION CONTAINING RANITIDINE IN THE FORM OF GELATINE CAPSULES.
EP0152292A3 (en) Acetaminophen gelatin capsules
KR870001830A (en) Process for producing high temperature melt terpenadine composition
HUP9903855A2 (en) Pharmaceutical microspheres of valproic acid for oral administration
KR960021018A (en) Pharmaceutical composition
RU98115892A (en) PHARMACEUTICAL COMPOSITION CONTAINING CYCLOSPORIN, METHOD FOR PRODUCING SOFT GELATINE CAPSULES, TREATMENT METHOD
PL325832A1 (en) Preparations in the form of soft capsules containing cyclosporin
RU98105629A (en) DRUGS CONTAINING CYCLOSPORIN, IN THE FORM OF SOFT COATED CAPSULES
JPS649932A (en) Soft capsule preparation using newly combined component as the base
BRPI9802667E2 (en) cyclosporine-containing composition
BR9802667C1 (en) Composition containing cyclosporine
FR2281106A1 (en) NEW ARRHYTHMIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AS ACTIVE SUBSTANCES